Yeleswaram Krishnaswamy (CIK 2022156) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-26). Recent activity: Sell RAPP (13,160 shares), Sell RAPP (20,799 shares), Sell RAPP (16,201 shares), Sell RAPP (404 shares), Sell RAPP (20,225 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-26 | Rapport Therapeutics, Inc. (RAPP) | Chief Development Officer | Sell | 13,160 | $657,978 |
| 2026-08-26 | Rapport Therapeutics, Inc. (RAPP) | Chief Development Officer | Sell | 20,799 | $1.0M |
| 2026-08-26 | Rapport Therapeutics, Inc. (RAPP) | Chief Development Officer | Sell | 16,201 | $827,184 |
| 2026-08-20 | Rapport Therapeutics, Inc. (RAPP) | Chief Development Officer | Sell | 404 | $20,160 |
| 2026-04-21 | Rapport Therapeutics, Inc. (RAPP) | Chief Development Officer | Sell | 20,225 | $808,798 |
| 2026-04-14 | Rapport Therapeutics, Inc. (RAPP) | Chief Development Officer | Sell | 500 | $17,490 |
| 2026-04-14 | Rapport Therapeutics, Inc. (RAPP) | Chief Development Officer | Sell | 9,165 | $320,500 |
| 2026-04-14 | Rapport Therapeutics, Inc. (RAPP) | Chief Development Officer | Sell | 10,200 | $357,816 |
| 2026-04-09 | Rapport Therapeutics, Inc. (RAPP) | Chief Development Officer | Sell | 360 | $12,564 |
| 2026-03-26 | Rapport Therapeutics, Inc. (RAPP) | Chief Development Officer | Sell | 10,115 | $303,349 |
| 2026-01-05 | Rapport Therapeutics, Inc. (RAPP) | Chief Development Officer | Buy | 9,000 | $0 |
| 2026-01-05 | Rapport Therapeutics, Inc. (RAPP) | Chief Development Officer | Sell | 2,840 | $85,342 |
来源：SEC Form 4 申报文件 · 截至 2026-08-26